Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Universitaire Ziekenhuizen KU Leuven
University of Southern California
Mayo Clinic
Lund University Hospital
University of Washington
City of Hope Medical Center
Radiation Therapy Oncology Group
University of California, San Francisco
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center